Treatment
Medication clinical trials
We’re tracking 7,446 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07032818Recruiting
Helping patients go home safely after a hospital stay
This study tests a program to help patients with limited English get the support they need when leaving the hospital. If you speak Spanish, Haitian Creole, Portuguese, Cape Verdean, or Vietnamese and are being discharged home from Boston Medical Center, you may be able to join.
Boston, MassachusettsAges 18 years+ - NCT07032961Recruiting
Capsule camera screening for stomach issues
This study is testing a new, less invasive way to screen for stomach problems using a tiny capsule that you swallow. It's for older adults or those at higher risk of stomach cancer who live in Guangzhou.
Guangzhou, GuangdongAges 45 years+ - NCT07033260Recruiting
Carotid ultrasound to predict low blood pressure during dialysis
This study looks at whether an ultrasound of the carotid artery (the main artery in your neck) can help predict drops in blood pressure during dialysis. It may help doctors find people at risk for low blood pressure during treatment.
Wuhu, Outside of the USAges 18–80 - NCT07033572Recruiting
Hybrid scope surgery and ablation for both sides of thyroid cancer
This study tests a combined approach—removing the main thyroid cancer with a tiny camera (endoscope) and using targeted heat to destroy a small nodule on the opposite side. It aims to treat both sides of the thyroid at once with less scarring and faster recovery.
Fuzhou, FujianAges 18–65 - NCT07033819RecruitingPhase 2
Fuzuloparib and apatinib before surgery for ovarian cancer
This trial tests a combination of two oral drugs—fuzuloparib (a PARP inhibitor) and apatinib (which blocks blood vessel growth to tumors)—given before surgery for advanced ovarian cancer that cannot be removed right away. It is for people whose tumors have a specific genetic marker (HRD positive) and who have not had prior cancer treatment.
Beijing, Beijing MunicipalityAges 18–70 - NCT07034391RecruitingPhase 2
PD-1 inhibitor with denosumab and chemo for advanced lung cancer
This trial tests a combination of an immunotherapy drug (PD-1 inhibitor), a bone-strengthening drug (denosumab), and chemotherapy for people with advanced or spread non-squamous non-small cell lung cancer that does not have certain genetic changes. The goal is to see if this combination helps shrink tumors and control the disease.
Shenyang, LiaoningAges 18–75 - NCT07035847Recruiting
Transaxillary TAVR guided by ultrasound only
This trial is testing a new way to replace your aortic valve using a small tube through your armpit, guided only by ultrasound (echocardiography) instead of X-rays. It may be an option if you have severe aortic stenosis and are a good fit for this less invasive approach.
Beijing, Beijing MunicipalityAges Any age - NCT07036731Recruiting
Urine test study for second bladder surgery
This trial compares the need for a second surgery for people with early-stage bladder cancer. It uses a simple urine test to see if the test can help decide whether a second operation is necessary, which could save some patients from an extra procedure.
Nanjing, JiangsuAges 18–80 - NCT07037004RecruitingPhase 2
Testing a gut health supplement with immunotherapy after kidney cancer surgery
This trial is testing whether adding a gut health supplement (CBM588) to the immunotherapy drug pembrolizumab can help prevent kidney cancer from returning after surgery. It is for people with certain types of kidney cancer who have not had immunotherapy before.
Duarte, CaliforniaAges 18 years+ - NCT07037472Recruiting
Imaging calcium deposits in dermatomyositis patients
This study uses a special imaging technique (photoacoustic/ultrasound) to look at calcium deposits under the skin in people with dermatomyositis. It aims to find patterns that help doctors understand the condition and track how well treatments work.
BeijingAges 18–80 - NCT07037563Recruiting
AI chatbot for managing diabetes, blood pressure, or cholesterol
This trial is testing a new AI chatbot that helps people in Hong Kong manage their health conditions like high blood sugar, high blood pressure, or high cholesterol. If you take medication for one of these conditions or care for someone who does, you may be able to join.
Hong KongAges 18 years+ - NCT07038304RecruitingPhase 2
Radiation for cancer growth in prostate cancer that stopped responding to hormones
This trial tests whether giving precise radiation to a few spots of cancer growth can help control prostate cancer that has stopped responding to hormone therapy. It is for people with up to 3 growing or new spots of cancer on a special scan.
GroningenAges 18 years+ - NCT07038629RecruitingPhase 2
Chemo, radiation, and immunotherapy for older adults with esophageal cancer
This trial tests combining chemoradiation with the immunotherapy drug iparomlimab for adults aged 70 and older with advanced esophageal cancer. The goal is to see if adding immunotherapy after standard chemoradiation improves outcomes.
Tianjin, Tianjin MunicipalityAges 70–90 - NCT07039305Recruiting
Building physical strength after stroke
This study looks at whether a specific exercise program can help people with chronic stroke (more than 6 months ago) who still have some weakness in their leg. It aims to improve walking and overall physical ability.
Charleston, South CarolinaAges 18–80 - NCT07039396Recruiting
NeoThelium FT for diabetic foot ulcers
This trial tests a new treatment called NeoThelium FT for diabetic foot ulcers. It aims to see if the treatment is safe and helps heal the ulcer. You may join if you have a diabetic foot ulcer that is not infected.
Alexandria, LouisianaAges 18 years+ - NCT07040306Recruiting
Follow-up study on drug therapy for Graves' disease
This study looks at how well medication works for people with Graves' disease in China. It may help doctors understand the best treatment options for both new cases and relapses.
Shenyang, LiaoningAges 18 years+ - NCT07040592RecruitingPhase 2
Semaglutide for HIV and alcohol use
This study is testing whether semaglutide, a medication already used for diabetes and weight loss, can help people with HIV who also have an alcohol use disorder cut back on drinking. It is for patients treated at the Atlanta VA Healthcare System.
Decatur, GeorgiaAges 18–99 - NCT07041034Recruiting
Managing behavioral symptoms in dementia at long-term care
This trial tests a new approach to help manage behavioral and psychological symptoms of dementia (BPSD) for people living in long-term care facilities. It aims to improve care and quality of life for residents with dementia.
New Taipei CityAges 65–110 - NCT07041268RecruitingPhase 2
Rituximab for recent type 1 diabetes in teens
This trial tests if repeated infusions of rituximab (a drug that calms the immune system) can help preserve insulin production in adolescents newly diagnosed with type 1 diabetes. It is for teens in Russia who started diabetes treatment within the last 4 months.
MoscowAges 12–18 - NCT07041450Recruiting
Screening for Alzheimer's treatment using digital tests and blood tests
This study is testing whether simple digital memory tests and blood tests can help find people who might qualify for anti-amyloid treatments (medications that target Alzheimer's-related proteins). It aims to make screening easier and faster, without needing a spinal tap or PET scan.
Greenfield Park, QuebecAges 55–90 - NCT07042217Recruiting
Brain stimulation for depression
This trial tests if a gentle electrical current applied to the head can help people with major depression. It's for adults currently in a depressive episode who haven't found relief from at least two previous antidepressants.
Woodbridge, New JerseyAges 22 years+ - NCT07042438RecruitingPhase 2
Fecal transplant to improve CAR T therapy for lymphoma
This study tests whether a fecal transplant (transferring healthy gut bacteria) can improve outcomes for people with certain lymphomas who have taken strong antibiotics and are about to get CAR T-cell therapy (Yescarta). The goal is to see if rebuilding gut bacteria helps the treatment work better.
Duarte, CaliforniaAges 18 years+ - NCT07043270RecruitingPhase 2
Alternating chemo regimens for borderline resectable pancreatic cancer
This trial compares two chemotherapy regimens — GnP (gemcitabine and nab-paclitaxel) and mFOLFIRINOX — given in alternating cycles for people with borderline resectable pancreatic cancer. The goal is to see if this alternating approach can shrink the tumor enough to allow surgery.
Lebanon, New HampshireAges 18 years+ - NCT07043426Recruiting
Diabetes care support for social needs
This study tests if connecting people with type 2 diabetes who have high A1C levels (9% or more) to community resources for social needs (like food or housing) can help improve their diabetes control. It aims to see if addressing life challenges outside the clinic helps lower blood sugar.
Boston, MassachusettsAges 18 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,446 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.